- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 1.25B sh |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $34.1B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $35.17B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $42.06B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $42.93B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.19B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $3.24B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.27B sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$894M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $7.84B |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $8.1B |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.29 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.29 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $411M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $228M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $368M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $3.2B |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.13B |